Beyond Doubt: Measure Your Site Engagement 

This webinar provides unique oversight metrics that support proactive adjustments to keep your study on time and on budget.

For too long, sponsors have relied on anecdotal evidence that often comes too late. Analyzing years of data, we have now identified leading indicators of site engagement that can be leveraged to improve study success. For the first time ever, you can benchmark your site engagement health and proactively measure improvement over time.

Insight on the leading indicators of site engagement that improve clinical trial outcomes

Real-world examples of small adjustments with big impact on recruitment and retention

With our unique oversight metrics, you'll have data to support proactive adjustments that keep your study on time and on budget.

A new approach to quantifying site engagement

Communication Best Practices for Enhanced Site Engagement

This webinar shares the real-world study outcomes of using best practice communications to nurture site relationships.

This webinar provides practical steps to implement best practices across clinical trial communications and build site relationships that last.

Communication Best Practices for Enhanced Site Engagement (Recorded Webinar)

Progressive study teams have a new approach to build lasting relationships with their study sites. What’s the secret? Watch this webinar where our panel shares proven, practical tips for best-in-class site engagement.

In the webinar, we share several case studies from leading pharma companies who are using targeted, timely site communication campaigns. Here’s a taster of the results…

A timely turnaround for poor recruiting sites

The uncovering of specific eligibility criteria blocking recruitment

A significant increase in site engagement

In this follow-up session, our hosts Brian Deighan and Ger Sweeney answer questions posed during the webinar.

Apply communication best practices to clinical trial outreach to build site relationships that last

Enabling Sites for Outcomes

How to ensure tech evaluation starts with the end in mind for more efficient clinical trials.

Enabling Sites for Outcomes 

Enabling Clinical Trial Sites for Outcomes 💡 (Recorded Webinar)

In the last year, clinical trial operations were forced to welcome alternative technological approaches to alleviate disruptions from the global pandemic. With the dust settled a bit and a taste of the increased efficiency and visibility offered by these approaches, many are considering how to leverage this momentum to optimize use of technology beyond disruption management. But how can all study stakeholders maximize the benefit of the technology on offer?

This panel discussion is designed to equip senior leadership in clinical operations with a framework to select and evaluate innovation and manage change to optimize clinical trials not only for today but with lasting effects for the future. Rather than reviewing tactical decisions about point solutions, this industry discussion gives you tips and insights from key trial stakeholders on how to ensure your evaluation of technology starts with the end in mind and supports faster, safer, more efficient clinical trials.

Moderated by Malia Lewin, Teckro's global head of strategy, panelists also include:

Lydia Beaudette, manager of growth & strategic partnerships, 

Silvina Baudino, Teckro director, site strategy

Tips and insights from key stakeholders on how to ensure technology evaluation starts with the end in mind for faster, safer, more efficient clinical trials.

Webinar: Enabling Clinical Trial Sites for Outcomes

Fundamental principles for today’s clinical trials

Improving Clinical Trial Communication

Teckro discuss how to improve clinical trial efficiency through effective communication.

Closing the Gap in Clinical Trial Communication

Close the Gap! How Bad Communication Affects Clinical Trial Outcomes 🤦‍♂️ (Recorded Webinar)

Inefficient and out-dated modes of communication have a direct impact on time, cost, quality and visibility when conducting clinical trials.

Clinical trial success depends on effective communication between study teams and research personnel. However, we know that many sponsors aren’t really sure how best to communicate in ways that help their sites. And on the other side, we know research staff are frustrated at how long it can take to get answers from study experts.

On May 25, Teckro participated in the Outsourcing in Clinical Trials East Coast Virtual Conference. In this webinar, we discuss how Teckro can connect investigators and site staff with study instruction and expert guidance when and where they need it. And how study teams can gain essential insight into trial performance and engagement.

Moderated by Kelly Brown, chief marketing officer at Teckro, this session was presented by:

Andrea Parish, Teckro head, operational excellence

Teckro participated in the OCT East Coast 2021 Virtual Conference to discuss improving time, cost, quality and visibility of clinical trials through effective communication.

Webinar: Closing the Gap in Clinical Trials Communications

Presented during the Outsourcing in Clinical Trials East Coast Virtual Conference

Achieving Diversity and Inclusion in Clinical Trials

Cassandra Smith considers patient diversity issues and ways to increase inclusion.

Achieving Diversity and Inclusion in Clinical Trials 🗺 (Recorded Webinar)

Clinical trials should be accessible to the population suffering from the illness. However, underrepresentation in clinical trials by racial and ethnic minorities continues to be a multi-layered problem.

Cassandra Smith, Director of Diversity and Inclusion in Clinical Trials Lead, Janssen R&D looks at why a changing global population requires more clinical trial diversity for the future of drug development and what role sponsors can play to make trials more accessible to all patients.

Cassandra originally presented this segment in a longer webinar addressing clinical trial inclusion and diversity titled "

No One Left Behind: Addressing Clinical Trial Access and Issues Blocking Physician Participation

Cassandra Smith of Janssen looks at the lack of clinical trial diversity in drug development and how sponsors can improve accessibility for greater inclusion.

Webinar: Achieving Patient Diversity and Inclusion in Clinical Trials

Webinar: Achieving Diversity and Inclusion in Clinical Trials

The Current State of the Protocol

Tufts CSDD Deputy Director Ken Getz presents research on site staff protocol referencing.

Webinar: The Current State of the Protocol

The Current State of the Clinical Trial Protocol 🗄🖥 (Recorded Webinar)

In the last decade, protocol design has become increasingly complex with significantly more endpoints, inclusion/exclusion criteria and distinct procedures. Still, research staff are heavily reliant on paper and desktop computers to access the protocol instruction. Ken Getz, deputy director for the Tufts Center for the Study of Drug Development (CSDD) presents the current state of protocol design and complexity facing investigative research staff.

Ken originally presented this segment in a longer webinar addressing clinical trial inclusion and diversity titled "

Full results are available in the new report 

Tufts CSDD – Teckro 2020 Study on Investigative Site Protocol Administration Referencing Practices.

Tufts CSDD Deputy Director Ken Getz presents research on the difficulties encountered by investigative site staff accessing and referring to protocol information.

Webinar: The Current State of the Clinical Trial Protocol

Tufts CSDD – Teckro Industry Research on Investigative Site Protocol Perceptions

No One Left Behind: Trial Access and Physician Participation

Teckro's Kelly Brown moderates a discussion with experts on trial accessibility.

No One Left Behind: Trial Access and Physician Participation ⛑ (Recorded Webinar)

How do we make clinical trials simpler for clinical staff so they want to participate, therefore increasing accessibility to a broader number of patients? In this webinar, we look at the current challenges with clinical trial diversity, and what steps we can take to make trials more accessible for both patients and physicians.

Moderated by Kelly Brown, Teckro Chief Marketing Officer, the session features a roundtable discussion of experts:

Ken Getz, Deputy Director of the Tufts Center for the Study of Drug Development

Cassandra Smith, Director, Diversity and Inclusion in Clinical Trials Lead, Janssen R&D

Dr. Brendan Buckley, Teckro Chief Medical Officer

During the session, Ken introduced new industry research on 

investigative site perceptions of clinical trial protocols

Considerations to Overcome Clinical Trial Accessibility Challenges

With so many questions during the session, we didn't have time to answer everything. So, our presenters contributed to a FAQ to provide additional thoughts. 

This expert panel discussion includes Ken Getz of Tufts CSDD, Cassandra Smith of Janssen R&D and Teckro's Dr. Brendan Buckley on making clinical trials more accessible.

Webinar: Addressing Clinical Trial Access and Physician Participation

Addressing clinical trial access and issues blocking physician participation

No One Left Behind

Tackling Cancer by Advancing Clinical Trials

We examine challenges with cancer trials, recruitment and patient safety.

Advancing Cancer Clinical Trials by Connecting Sites, Sponsors and Monitors 🔃 (Recorded Webinar)

Some Hero Title

In this webinar, we look at the current challenges with cancer trials from the individual viewpoints of research site staff, monitors and sponsors. Then we explore the benefits of connecting all stakeholders with a digital engagement platform to speed recruitment, reduce non-compliance, and improve patient safety.

This session features a panel of experts:

Ozgur Karakuzu, Senior Clinical Study Coordinator at MD Anderson Cancer Center

Andrea Parish, Teckro Head of Operational Excellence in Professional Services

Rita Frawley, Teckro Program Lead in Professional Services

This webinar examines challenges with cancer trials, how to connect sites, sponsors and monitors and how to speed recruitment while improving patient safety.

Webinar: Better Stakeholder Connections to Advance Cancer Trials

Advance Clinical Trials and Tackle Cancer by Connecting Research Sites, Sponsors and Monitors

Typical Study Protocol Challenges

We look at study stakeholder issues with poor accessibility to paper clinical trial protocols.

Is Your Clinical Trial Protocol Fit for Purpose?

Is Your Clinical Trial Protocol Fit for Purpose? 🤔 (Recorded Webinar)

While incredible advancements have been made with modern medicine, more can be done. To that end, we believe that clinical research must be more simple, transparent and accessible.

This webinar looks at the challenges for study stakeholders with paper clinical trial protocols. And it details the opportunities to transform the protocol into accessible, actionable information for research staff, monitors and sponsors – any time, everywhere.

This webinar looks at how to transform clinical trial protocols into easily accessible, actionable information for research staff and monitors.

Read

Listen

Watch

On Demand Webinars

Beyond Doubt: Measure Your Site Engagement

Communication Best Practices for Enhanced Site Engagement

Enabling Sites for Outcomes

Closing the Gap in Clinical Trial Communication

Achieving Diversity and Inclusion in Clinical Trials

Webinar: The Current State of the Protocol

No One Left Behind: Trial Access and Physician Participation

Tackling Cancer by Advancing Clinical Trials

Is Your Clinical Trial Protocol Fit for Purpose?

More Learning Resources

Blog

Podcast

Videos